The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection

The persistent public health threat of infection with the Middle East respiratory syndrome coronavirus (MERS-CoV) highlights the need for an effective MERS-CoV vaccine. Previous studies have focused mainly on the receptor-binding domain (RBD) on the spike protein of MERS-CoV. Herein, we investigated...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiaming, Lan, Yanfeng, Yao, Yao, Deng, Yawei, Hu, Linlin, Bao, Baoying, Huang, Jinghua, Yan, Gao, George F., Chuan, Qin, Wenjie, Tan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115548/
https://www.ncbi.nlm.nih.gov/pubmed/27899228
http://dx.doi.org/10.1016/j.vaccine.2016.11.064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115548/
https://www.ncbi.nlm.nih.gov/pubmed/27899228
http://dx.doi.org/10.1016/j.vaccine.2016.11.064

Ejemplares similares